Skip to main content
. 2015 Oct 9;91(8):410–422. doi: 10.2183/pjab.91.410

Figure 2.

Figure 2.

Relative enrichment of RA risk genes in the targets of RA drugs. RA risk genes and the genes in protein-protein interaction (PPI) are significantly enriched in overlap with target genes of approved RA treatment drugs, compared to overlap with target genes of existing drugs for all diseases. Representative connections between RA risk genes and targets of RA treatment drugs are labeled.